{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T20:52:07Z","timestamp":1686171127588},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1038\/s41584-022-00775-7","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T11:03:17Z","timestamp":1649242997000},"page":"307-308","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting necroptosis for the treatment of myositis"],"prefix":"10.1038","volume":"18","author":[{"given":"Kanneboyina","family":"Nagaraju","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,6]]},"reference":[{"key":"775_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/ART.42071","author":"Q Peng","year":"2022","unstructured":"Peng, Q. et al. Necroptosis contributes to myofiber death in idiopathic inflammatory myopathies. Arthritis Rheumatol. https:\/\/doi.org\/10.1002\/ART.42071 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"775_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27875-4","volume":"13","author":"M Kamiya","year":"2022","unstructured":"Kamiya, M. et al. Targeting necroptosis in muscle fibers ameliorates inflammatory myopathies. Nat. Commun. 13, 166 (2022).","journal-title":"Nat. Commun."},{"key":"775_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.01887","author":"LM Schwartz","year":"2019","unstructured":"Schwartz, L. M. Skeletal muscles do not undergo apoptosis during either atrophy or programmed cell death-revisiting the myonuclear domain hypothesis. Front. Physiol. https:\/\/doi.org\/10.3389\/fphys.2018.01887 (2019).","journal-title":"Front. Physiol."},{"key":"775_CR4","first-page":"1","volume":"58","author":"R Qaisar","year":"2014","unstructured":"Qaisar, R. & Larsson, L. What determines myonuclear domain size? Indian J. Physiol. Pharmacol. 58, 1\u201312 (2014).","journal-title":"Indian J. Physiol. Pharmacol."},{"key":"775_CR5","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1152\/japplphysiol.00084.2005","volume":"99","author":"PM Siu","year":"2005","unstructured":"Siu, P. M., Bryner, R. W., Murlasits, Z. & Alway, S. E. Response of XIAP, ARC, and FLIP apoptotic suppressors to 8 wk of treadmill running in rat heart and skeletal muscle. J. Appl. Physiol. 99, 204\u2013209 (2005).","journal-title":"J. Appl. Physiol."},{"key":"775_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-5728(99)00162-9","volume":"106","author":"M Li","year":"2000","unstructured":"Li, M. & Dalakas, M. C. Expression of human IAP-like protein in skeletal muscle: a possible explanation for the rare incidence of muscle fiber apoptosis in T-cell mediated inflammatory myopathies. J. Neuroimmunol. 106, 1\u20135 (2000).","journal-title":"J. Neuroimmunol."},{"key":"775_CR7","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.4049\/jimmunol.164.10.5459","volume":"164","author":"K Nagaraju","year":"2000","unstructured":"Nagaraju, K. et al. The inhibition of apoptosis in myositis and in normal muscle cells. J. Immunol. 164, 5459\u20135465 (2000).","journal-title":"J. Immunol."},{"key":"775_CR8","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.2353\/ajpath.2010.090058","volume":"176","author":"R Rawat","year":"2010","unstructured":"Rawat, R. et al. Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle. Am. J. Pathol. 176, 2891\u20132900 (2010).","journal-title":"Am. J. Pathol."},{"key":"775_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1365-2249.2006.03180.x","volume":"146","author":"M Tucci","year":"2006","unstructured":"Tucci, M., Quatraro, C., Dammacco, F. & Silvestris, F. Interleukin-18 overexpression as a hallmark of the activity of autoimmune inflammatory myopathies. Clin. Exp. Immunol. 146, 21\u201331 (2006).","journal-title":"Clin. Exp. Immunol."},{"key":"775_CR10","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1093\/rheumatology\/keaa473","volume":"60","author":"D Liu","year":"2021","unstructured":"Liu, D. et al. PKM2-dependent glycolysis promotes skeletal muscle cell pyroptosis by activating the NLRP3 inflammasome in dermatomyositis\/polymyositis. Rheumatology 60, 2177\u20132189 (2021).","journal-title":"Rheumatology"}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-022-00775-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-022-00775-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-022-00775-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T13:04:47Z","timestamp":1653570287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-022-00775-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["775"],"URL":"https:\/\/doi.org\/10.1038\/s41584-022-00775-7","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,6]]},"assertion":[{"value":"6 April 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}